Display of Hepatitis B Virus PreS1 peptide on bacteriophage T7 and its potential in gene delivery into HepG2 cells

Journal of Virological Methods

Volumn 159, Issue 2, 2009, Pages 194-199

  Tang, Kie Hie ^a   Yusoff, Khatijah ^a,b   Tan, Wen Siang ^a,b  

^a Faculty of Biotechnology and Biomolecular Sciences   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Hepatitis B surface antigen; Hepatocytes; Phage vectors; Transduction

Indexed keywords

AMINO ACID; PRES1 PEPTIDE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ARTICLE; BACTERIOPHAGE T7; CANCER GENE THERAPY; CELL LYSATE; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE TRANSFER; GENETIC MANIPULATION; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; INTERNALIZATION; LIVER CANCER; NONHUMAN; PHAGE DISPLAY; PLAQUE FORMING CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME;

BACTERIOPHAGE T7; CELL LINE; DNA, VIRAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; PLAQUE ASSAY; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; TRANSDUCTION, GENETIC;

HEPATITIS B VIRUS;

EID: 67349206567     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.03.015     Document Type: Article

References (30)

1. Barrera A., Guerra B., Lee H., and Lanford R.E. Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes. J. Virol. 78 (2004) 5233-5243
2. Bosch F.X., Ribes J., Diaz M., and Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 (2004) S5-S16
3. Bruss V., and Ganem D. The role of envelope proteins in hepatitis B virus assembly. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 1059-1063
4. Chen B.Y., and Lim H.C. Bioreactor studies on temperature induction of the Q-mutant of bacteriophage lambda in Escherichia coli. J. Biotechnol. 51 (1996) 1-20
5. Dash S., Rao K.V.S., and Panda S.K. Receptor for Pre-S1 (21-47) component of hepatitis B virus on the liver cell: role in virus cell interaction. J. Med. Virol. 37 (1992) 116-121
6. De Falco S., Ruvoletto M.G., Verdoliva A., Ruvo M., Raucci A., Marino M., Senatore S., Cassani G., Alberti A., Pontisso P., and Fassina G. Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J. Biol. Chem. 276 (2001) 36613-36623
7. Geier M.R., and Merril C.R. Lambda phage transcription in human fibroblasts. Virology 47 (1972) 638-643
8. Hart S.L., Knight A.M., Harbottle R.P., Mistry A., Hunger H.D., Cutler D.F., Williamson R., and Coutelle C. Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J. Biol. Chem. 269 (1994) 12468-12474
9. Ishikawa T., Kuroki K., Lenhoff R., Summers J., and Ganem D. Analysis of the binding of a host cell surface glycoprotein to the preS protein of duck hepatitis B virus. Virology 202 (1994) 1061-1064
10. Jepson C.D., and March J.B. Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Vaccine 22 (2004) 2413-2419
11. Kok W.L., Yusoff K., Nathan S., and Tan W.S. Cloning, expression and display of the PreS domain of hepatitis B virus on filamentous bacteriophage M13. J. Biochem. Mol. Biol. Biophys. 6 (2002) 55-58
12. Lankes H.A., Zanghi C.N., Santos K., Capella C., Duke C.M.P., and Dewhurst S. In vivo gene delivery and expression by bacteriophage lambda vectors. J. Appl. Microbiol. 102 (2007) 1337-1349
13. Liang Y., Shi B., Zhang J., Jiang H., Xu Y., Li Z., and Gu J. Better gene expression by (-) gene than by (+) gene in phage gene delivery systems. Biotechnol. Prog. 22 (2006) 626-630
14. Neurath A.R., Kent S.B.H., Strick N., and Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46 (1986) 429-436
15. Paran N., Geiger B., and Shaul Y. HBV infection of cell culture: evidence for multivalent and cooperative attachment. EMBO J. 20 (2001) 4443-4453
16. Perz J.F., Armstrong G.L., Farrington L.A., Hutin Y.J., and Bell B.P. The contribution of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 45 (2006) 529-538
17. Petit M.A., Dubanchet S., Capel F., Voet P., Dauguet C., and Hauser P. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1 (21-47). Virology 180 (1991) 483-491
18. Petit M.A., Strick N., Dubanchet S., Capel F., and Neurath A.R. Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands. Mol. Immunol. 28 (1991) 517-521
19. Pontisso P., Ruvoletto M.G., Gerlich W.H., Heermann K.H., Bardini R., and Alberti A. Identification of an attachment site for human liver plasma membrane on hepatitis B virus particles. Virology 173 (1989) 522-530
20. Romano G., Michell P., Pacilio C., and Giordano A. Latest developments in gene transfer technology: achievements, perspectives and controversies over therapeutic applications. Stem Cells 18 (2000) 19-39
21. Rosenberg A., Griffin K., Studier W., McCormick M., Berg J., Novy R., and Mierendolf R. T7 select phage display system: a powerful new protein display system based on bacteriophage T7. Novations Novagen. Newslett. 6 (1996) 1-6
22. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., and Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev. 28 (2006) 112-125
23. Stone R. Bacteriophage therapy: Stalin's forgotten cure. Science 298 (2002) 728-731
24. Swanson J.A., and Watts C. Macropinocytosis. Trends Cell Biol. 5 (1995) 424-428
25. Tan G.H., Yusoff K., Seow H.F., and Tan W.S. Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7. J. Med. Virol. 77 (2005) 475-480
26. Tan W.S., Dyson M.R., and Murray K. Two distinct segments of the hepatitis B virus surface antigen contribute synergistically to its association with the viral core particles. J. Mol. Biol. 286 (1999) 797-808
27. Urban S., and Gripon P. Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein. J. Virol. 76 (2002) 1986-1990
28. Verma I.M., and Somia N. Gene therapy: promises, problems and prospects. Nature 389 (1997) 239-242
29. Yokoyama-Kobayashi M., and Kato S. Recombinant f1 phage-mediated transfection of mammalian cells using lipopolyamine technique. Anal. Biochem. 223 (1994) 130-134
30. Zenni M.K., Giardina P.C., Harvey H.A., Shao J., Ketterer M.R., Lubaroff D.M., Williams R.D., and Apicella M.A. Macropinocytosis as a mechanism of entry into primary human urethral epithelial cells by Neisseria gonorrhoeae. Infect. Immun. 68 (2000) 1696-1699